Author
Listed:
- Loes M. Stevers
(Eindhoven University of Technology)
- Madita Wolter
(Eindhoven University of Technology)
- Graeme W. Carlile
(McGill University)
- Dwight Macdonald
(Cyclenium Pharma Inc., 7171 rue Frederick Banting)
- Luc Richard
(Cyclenium Pharma Inc., 7171 rue Frederick Banting)
- Frank Gielkens
(Eindhoven University of Technology)
- John W. Hanrahan
(McGill University)
- David Y. Thomas
(McGill University)
- Sai Kumar Chakka
(Cyclenium Pharma Inc., 7171 rue Frederick Banting)
- Mark L. Peterson
(Cyclenium Pharma Inc., 7171 rue Frederick Banting)
- Helmut Thomas
(Cyclenium Pharma Inc., 7171 rue Frederick Banting)
- Luc Brunsveld
(Eindhoven University of Technology)
- Christian Ottmann
(Eindhoven University of Technology)
Abstract
Impaired activity of the chloride channel CFTR is the cause of cystic fibrosis. 14-3-3 proteins have been shown to stabilize CFTR and increase its biogenesis and activity. Here, we report the identification and mechanism of action of a macrocycle stabilizing the 14-3-3/CFTR complex. This molecule rescues plasma membrane localization and chloride transport of F508del-CFTR and works additively with the CFTR pharmacological chaperone corrector lumacaftor (VX-809) and the triple combination Trikafta®. This macrocycle is a useful tool to study the CFTR/14-3-3 interaction and the potential of molecular glues in cystic fibrosis therapeutics.
Suggested Citation
Loes M. Stevers & Madita Wolter & Graeme W. Carlile & Dwight Macdonald & Luc Richard & Frank Gielkens & John W. Hanrahan & David Y. Thomas & Sai Kumar Chakka & Mark L. Peterson & Helmut Thomas & Luc B, 2022.
"Macrocycle-stabilization of its interaction with 14-3-3 increases plasma membrane localization and activity of CFTR,"
Nature Communications, Nature, vol. 13(1), pages 1-9, December.
Handle:
RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-31206-6
DOI: 10.1038/s41467-022-31206-6
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-31206-6. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.